Article
The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes.
Journal of cellular physiology - 1 Jan 2022
Del Bosque-Plata Laura, Hernández-Cortés Eduardo Pavel, Gragnoli Claudia
Abstract excerpt
The TCF7L2 protein is a key transcriptional effector of the Wnt/β-catenin signaling pathway, regulating gene expression. It was initially identified in cancer research and embryologic developmental studies. Later, the TCF7L2 gene was linked to type 2 diabetes (T2D), implicating TCF7L2 and Wnt-signaling in metabolic disorders and homeostasis. In fact, TCF7L2-T2D variants confer the greatest relative risk for T2D,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
